134 related articles for article (PubMed ID: 28952709)
1. OPN b and c Isoforms Doubtless Veto Anti-angiogenesis Effects of Curcumin in Combination with Conventional AML Regiment.
Mirzaei A; Ghaffari SH; Nikbakht M; Kamranzadeh Foumani H; Vaezi M; Mohammadi S; Alimoghaddam K; Ghavamzadeh A
Asian Pac J Cancer Prev; 2017 Sep; 18(9):2591-2599. PubMed ID: 28952709
[TBL] [Abstract][Full Text] [Related]
2. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
[TBL] [Abstract][Full Text] [Related]
3. Curcumin Veto the Effects of Osteopontin (OPN) Specific Inhibitor on Leukemic Stem Cell Colony Forming Potential via Promotion of OPN Overexpression.
Mohammadi S; Ghaffari SH; Shaiegan M; Nikogoftar Zarif M; Nikbakht M; Alimoghaddam K; Ghavamzadeh A
Int J Hematol Oncol Stem Cell Res; 2016 Jul; 10(3):120-9. PubMed ID: 27489587
[TBL] [Abstract][Full Text] [Related]
4. Anti-Apoptotic Effects of Osteopontin via the Up-Regulation of AKT/mTOR/β-Catenin Loop in Acute Myeloid Leukemia Cells.
Zahed Panah M; Nikbakht M; Sajjadi SM; Rostami S; Norooznezhad AH; Kamranzadeh Fumani H; Ghavamzadeh A; Mohammadi S
Int J Hematol Oncol Stem Cell Res; 2017 Apr; 11(2):148-157. PubMed ID: 28875010
[No Abstract] [Full Text] [Related]
5. Osteopontin b and c isoforms: Molecular Candidates Associated with Leukemic Stem Cell Chemoresistance in Acute Myeloid Leukemia.
Mirzaei A; Mohammadi S; Ghaffari SH; Nikbakht M; Bashash D; Alimoghaddam K; Ghavamzadeh A
Asian Pac J Cancer Prev; 2017 Jun; 18(6):1707-1715. PubMed ID: 28670893
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal Interactions of Leukemic Cells with Bone Marrow Stromal Cells Promote Enrichment of Leukemic Stem Cell Compartments in Response to Curcumin and Daunorubicin.
Mohammadi S; Nikbakht M; Sajjadi SM; Rad F; Chahardouli B; Sabour Takanlu J; Rostami Sh; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Asian Pac J Cancer Prev; 2017 Mar; 18(3):831-840. PubMed ID: 28441794
[TBL] [Abstract][Full Text] [Related]
7. Anti-Vascular Endothelial Growth Factor Targeting by Curcumin and Thalidomide in Acute Myeloid Leukemia Cells.
Salemi M; Mohammadi S; Ghavamzadeh A; Nikbakht M
Asian Pac J Cancer Prev; 2017 Nov; 18(11):3055-3061. PubMed ID: 29172279
[TBL] [Abstract][Full Text] [Related]
8. Anti-Vascular Endothelial Growth Factor Effects of Sorafenib and Arsenic Trioxide in Acute Myeloid Leukemia Cell Lines.
Haghi A; Mohammadi S; Heshmati M; Ghavamzadeh A; Nikbakht M
Asian Pac J Cancer Prev; 2017 Jun; 18(6):1655-1661. PubMed ID: 28670885
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin plays a unique role in resistance of CD34+/CD123+ human leukemia cell lines KG1a to parthenolide.
Mohammadi S; Zahedpanah M; Ghaffari SH; Shaiegan M; Nikbakht M; Nikugoftar M
Life Sci; 2017 Nov; 189():89-95. PubMed ID: 28935249
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin b and c Splice isoforms in Leukemias and Solid Tumors: Angiogenesis Alongside Chemoresistance.
Mirzaei A; Mohammadi S; Ghaffari SH; Yaghmaie M; Vaezi M; Alimoghaddam K; Ghavamzadeh A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):615-623. PubMed ID: 29580029
[TBL] [Abstract][Full Text] [Related]
11. Combined anticancer effects of simvastatin and arsenic trioxide on prostate cancer cell lines via downregulation of the VEGF and OPN isoforms genes.
Mirzaei A; Rashedi S; Akbari MR; Khatami F; Aghamir SMK
J Cell Mol Med; 2022 May; 26(9):2728-2740. PubMed ID: 35366048
[TBL] [Abstract][Full Text] [Related]
12. Parthenolide Induces Apoptosis in Committed Progenitor AML Cell line U937 via Reduction in Osteopontin.
Zahedpanah M; Shaiegan M; Ghaffari SH; Nikbakht M; Nikugoftar M; Mohammadi S
Rep Biochem Mol Biol; 2016 Apr; 4(2):82-8. PubMed ID: 27536701
[TBL] [Abstract][Full Text] [Related]
13. Parthenolide reduces gene transcription of prosurvival mediators in U937 cells.
Mohammadi S; Zahedpanah M; Nikbakht M; Shaiegan M; Hamidollah G; Nikugoftar M; Rahmani B; Hamedi Asl D
Exp Oncol; 2017 Mar; 39(1):30-35. PubMed ID: 28361855
[TBL] [Abstract][Full Text] [Related]
14. Novel Curcumin Liposome Modified with Hyaluronan Targeting CD44 Plays an Anti-Leukemic Role in Acute Myeloid Leukemia in Vitro and in Vivo.
Sun D; Zhou JK; Zhao L; Zheng ZY; Li J; Pu W; Liu S; Liu XS; Liu SJ; Zheng Y; Zhao Y; Peng Y
ACS Appl Mater Interfaces; 2017 May; 9(20):16857-16868. PubMed ID: 28489348
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin is required for the maintenance of leukemia stem cells in acute myeloid leukemia.
Zhou J; Chen X; Zhou P; Sun X; Chen Y; Li M; Chu Y; Zhou J; Hu X; Luo Y; Yuan W; Wang G
Biochem Biophys Res Commun; 2022 Apr; 600():29-34. PubMed ID: 35182972
[TBL] [Abstract][Full Text] [Related]
16. Curcumin Enhanced Busulfan-Induced Apoptosis through Downregulating the Expression of Survivin in Leukemia Stem-Like KG1a Cells.
Weng G; Zeng Y; Huang J; Fan J; Guo K
Biomed Res Int; 2015; 2015():630397. PubMed ID: 26557682
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells.
Liu YN; Kang BB; Chen JH
Oncogene; 2004 Jan; 23(1):278-88. PubMed ID: 14712233
[TBL] [Abstract][Full Text] [Related]
18. Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells.
Zeng Y; Weng G; Fan J; Li Z; Wu J; Li Y; Zheng R; Xia P; Guo K
Oncol Rep; 2016 Sep; 36(3):1233-42. PubMed ID: 27430728
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.
Dai J; Peng L; Fan K; Wang H; Wei R; Ji G; Cai J; Lu B; Li B; Zhang D; Kang Y; Tan M; Qian W; Guo Y
Oncogene; 2009 Sep; 28(38):3412-22. PubMed ID: 19597469
[TBL] [Abstract][Full Text] [Related]
20. Curcumin suppresses breast tumor angiogenesis by abrogating osteopontin-induced VEGF expression.
Chakraborty G; Jain S; Kale S; Raja R; Kumar S; Mishra R; Kundu GC
Mol Med Rep; 2008; 1(5):641-6. PubMed ID: 21479462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
